Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anika Großhennig

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Contemporary Clinical Trials|September 22, 2020
COVID-19 hits a trial: Arguments against hastily deviating from the planAnika Großhennig, Armin Koch
Deutsches Arzteblatt International|June 27, 2024
Recognizing Statistical Problems in Reports of Clinical Trials: a Readers' Aid. Part 33 of a Series on Evaluation of Scientific PublicationsAnna Suling, Anika Großhennig
Chiropractic & Manual Therapies|September 7, 2018
Manual therapy applied by general practitioners for nonspecific low back pain: results of the ManRück pilot-studyHeidrun Lingner, Lena Blase, Anika Großhennig, et al.
Orphanet Journal of Rare Diseases|August 18, 2017
Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare diseaseLoukia M Spineli, Eva Jenz, Anika Großhennig, et al.
Pharmaceutical Statistics|May 22, 2023
How to avoid concerns with the interpretation of two primary endpoints if significant superiority in one is sufficient for formal proof of efficacyAnika Großhennig, Nele Henrike Thomas, Werner Brannath, et al.
British Journal of Clinical Pharmacology|August 27, 2025
Randomization in phase II trials: No exemption based on sample sizeTheodor Framke, Gernot Beutel, Arnold Ganser, et al.
Pharmaceutical Statistics|February 17, 2026
A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical TrialXiaofei Liu, Nele Henrike Thomas, Elina Asikanius, et al.
The International Journal of Social Psychiatry|December 4, 2014
How much orientation towards the host culture is healthy? Acculturation style as risk enhancement for depressive symptoms in immigrantsKatharina Behrens, Melina A del Pozo, Anika Großhennig, et al.
Trials|August 17, 2014
A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trialThurid Ahlenstiel-Grunow, Armin Koch, Anika Großhennig, et al.
Journal of Chiropractic Medicine|December 23, 2015
Manual Therapy by General Medical Practitioners for Nonspecific Low Back Pain in Primary Care: The ManRück Study Protocol of a Clinical TrialGuido Schmiemann, Lena Blase, Christoph Seeber, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Contemporary Clinical Trials|September 22, 2020
COVID-19 hits a trial: Arguments against hastily deviating from the planAnika Großhennig, Armin Koch
Deutsches Arzteblatt International|June 27, 2024
Recognizing Statistical Problems in Reports of Clinical Trials: a Readers' Aid. Part 33 of a Series on Evaluation of Scientific PublicationsAnna Suling, Anika Großhennig
Chiropractic & Manual Therapies|September 7, 2018
Manual therapy applied by general practitioners for nonspecific low back pain: results of the ManRück pilot-studyHeidrun Lingner, Lena Blase, Anika Großhennig, et al.
Orphanet Journal of Rare Diseases|August 18, 2017
Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare diseaseLoukia M Spineli, Eva Jenz, Anika Großhennig, et al.
Pharmaceutical Statistics|May 22, 2023
How to avoid concerns with the interpretation of two primary endpoints if significant superiority in one is sufficient for formal proof of efficacyAnika Großhennig, Nele Henrike Thomas, Werner Brannath, et al.
British Journal of Clinical Pharmacology|August 27, 2025
Randomization in phase II trials: No exemption based on sample sizeTheodor Framke, Gernot Beutel, Arnold Ganser, et al.
Pharmaceutical Statistics|February 17, 2026
A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical TrialXiaofei Liu, Nele Henrike Thomas, Elina Asikanius, et al.
The International Journal of Social Psychiatry|December 4, 2014
How much orientation towards the host culture is healthy? Acculturation style as risk enhancement for depressive symptoms in immigrantsKatharina Behrens, Melina A del Pozo, Anika Großhennig, et al.
Trials|August 17, 2014
A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trialThurid Ahlenstiel-Grunow, Armin Koch, Anika Großhennig, et al.
Journal of Chiropractic Medicine|December 23, 2015
Manual Therapy by General Medical Practitioners for Nonspecific Low Back Pain in Primary Care: The ManRück Study Protocol of a Clinical TrialGuido Schmiemann, Lena Blase, Christoph Seeber, et al.
Pageof 4